Gaciong, Zbigniew

• Vol 71, No 4 (2013) - Original articles
  Prevalence and control of cardiovascular risk factors in Poland. Assumptions and objectives of the NATPOL 2011 Survey
  Abstract  PDF
• Vol 74, No 4 (2016) - Experts' opinions and Positions papers
  Severe hypercholesterolaemia — when to use the proprotein convertase subtilisin-kexin type 9 protease inhibitors (PCSK9 inhibitors)? Polish Society of Cardiology experts’ group statement
  Abstract  PDF (Polish)  HTML (Polish)
• Vol 73, No 8 (2015) - Experts' opinions and Positions papers
  2015 guidelines for the management of hypertension. Recommendations of the Polish Society of Hypertension — short version
  Details  PDF  HTML
• Vol 73, No 10 (2015) - Experts' opinions and Positions papers
  A new version of cardiovascular risk assessment system and risk charts calibrated for Polish population
  Details  PDF (Polish)  HTML (Polish)
• Vol 75, No 12 (2017) - Expert consensus statement
  Single-pill combinations (SPCs) and treatment of arterial hypertension in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy
  Abstract  PDF
• Vol 70, No 2 (2012) - Commentary
  Świadomość zagrożeń dotyczących nadciśnienia w Polsce: stan obecny i sposób poprawy
  Details  PDF (Polish)
• Vol 64, No 5 (2006) - Other
  Evidence-based cardiology
  Clopidogrel and aspirin versus aspirin alone in prevention of atherothrombotic events. The results of CHARISMA study
  Details  PDF (Polish)
• Vol 67, No 10 (2009) - Other
  Comment to article
  Czy dabigatran jest idealnym lekiem przeciwzakrzepowym? Komentarz do badania RE-LY
  Details  PDF (Polish)
• Vol 67, No 6 (2009) - Other
  Original article
  Atorvastatin reduces sympathetic activity and increases baroreceptor reflex sensitivity in patients with hypercholesterolaemia and systemic arterial hypertension
  Abstract  PDF (Polish)